BARCLAYS PLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$22,796
-19.9%
599,289
+91.9%
0.01%
-22.2%
Q2 2023$28,443
+78.0%
312,230
+28.9%
0.02%
+157.1%
Q1 2023$15,975
+35.9%
242,181
+6.5%
0.01%
+40.0%
Q4 2022$11,756
-99.9%
227,347
+70.7%
0.01%
-50.0%
Q3 2022$9,095,000
+758.0%
133,149
+468.1%
0.01%
+900.0%
Q2 2022$1,060,000
-60.3%
23,436
-55.4%
0.00%
-50.0%
Q1 2022$2,672,000
-80.5%
52,604
-81.9%
0.00%
-33.3%
Q4 2021$13,734,000
+1047.4%
290,496
+700.4%
0.00%
Q3 2021$1,197,000
-49.0%
36,293
-2.2%
0.00%
-100.0%
Q2 2021$2,346,000
-40.6%
37,119
-59.7%
0.00%
-50.0%
Q1 2021$3,950,000
-22.1%
92,034
+3.8%
0.00%
-33.3%
Q4 2020$5,070,000
+4.5%
88,630
-44.9%
0.00%0.0%
Q3 2020$4,852,000
+134.1%
160,818
+153.2%
0.00%
+50.0%
Q2 2020$2,073,000
-59.3%
63,504
-66.6%
0.00%
-50.0%
Q1 2020$5,090,000
-85.7%
190,038
-83.6%
0.00%
-80.0%
Q4 2019$35,531,000
+3019.5%
1,160,434
+2356.0%
0.02%
+1900.0%
Q3 2019$1,139,000
-76.8%
47,249
-75.7%
0.00%
-66.7%
Q2 2019$4,920,000
+63.6%
194,138
+25.9%
0.00%
+50.0%
Q1 2019$3,007,000
+14219.0%
154,155
+9650.5%
0.00%
Q4 2018$21,000
-91.6%
1,581
-88.8%
0.00%
Q3 2018$251,000
+332.8%
14,054
+430.7%
0.00%
Q2 2018$58,000
+9.4%
2,648
+11.9%
0.00%
Q1 2018$53,000
+43.2%
2,367
+37.9%
0.00%
Q4 2017$37,0001,7170.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders